The use of nuclear scintigraphy to evaluate the anabolic effects of teriparatide on the skeleton in postmenopausal women with osteoporosis.

Trial Profile

The use of nuclear scintigraphy to evaluate the anabolic effects of teriparatide on the skeleton in postmenopausal women with osteoporosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2010

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jul 2007 Status changed from recruiting.
    • 31 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top